AGIOS PHARMACEUTICALS, INC. Gain (Loss) on Disposition of Assets
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Gain (Loss) on Disposition of Assets of -$1.05 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-19.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2020-02-19
- AGIOS PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2019-12-31 was -$586.00K.
- AGIOS PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2019-09-30 was -$466.00K.
- AGIOS PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2018-12-31 was -$40.00K.
- AGIOS PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2018-09-30 was $0.00.
- AGIOS PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2019 was -$1.05M.
- AGIOS PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2018 was -$20.00K.
- AGIOS PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2017 was -$40.00K.
- AGIOS PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2016 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$586.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$1.05M derived: sum of 2 quarters · filed 2020-02-19 | -$1.05M 10-K · filed 2020-02-19 | |
| 2019-09-30 | -$466.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$466.00K 10-Q · filed 2019-10-31 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-01 | |||
| 2018-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$40.00K derived: sum of 2 quarters · filed 2020-02-19 | -$20.00K derived: sum of 3 quarters · filed 2020-02-19 | -$20.00K 10-K · filed 2020-02-19 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $20.00K derived: sum of 2 quarters · filed 2019-10-31 | $20.00K 10-Q · filed 2019-10-31 | $20.00K derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $20.00K 10-Q · filed 2019-08-01 | $20.00K derived: sum of 3 quarters · filed 2020-02-19 | $20.00K derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-04 | $0.00 derived: sum of 2 quarters · filed 2020-02-19 | $0.00 derived: sum of 3 quarters · filed 2020-02-19 | $0.00 derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $0.00 derived: sum of 2 quarters · filed 2020-02-19 | $0.00 derived: sum of 3 quarters · filed 2020-02-19 | -$40.00K 10-K · filed 2020-02-19 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | -$40.00K 10-Q · filed 2018-11-01 | -$40.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$40.00K 10-Q · filed 2018-08-02 | -$40.00K derived: sum of 3 quarters · filed 2019-02-14 | -$40.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | -$40.00K 10-Q · filed 2018-05-04 | -$40.00K derived: sum of 2 quarters · filed 2019-02-14 | -$40.00K derived: sum of 3 quarters · filed 2019-02-14 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $0.00 derived: sum of 2 quarters · filed 2019-02-14 | $0.00 10-K · filed 2019-02-14 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 10-Q · filed 2017-11-01 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-08 | |||
| 2015-12-31 | -$33.00K 10-K · filed 2018-02-14 | |||
| 2012-12-31 | -$10.00K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |